1246280-91-0

Basic information

• Product Name: phosphoric acid ((2R,3S,4R,5R)-5-(3-carbamoyl-[1,2,4]-triazol-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-ylmethyl) ester 2-{[5-cyclopropyl-2-(4-fluorophenyl)-3-methylcarbamoylbenzofuran-6-yl]methanesulfonylamino}ethyl ester
• Synonyms: phosphoric acid ((2R,3S,4R,5R)-5-(3-carbamoyl-[1,2,4]-triazol-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-ylmethyl) ester 2-{[5-cyclopropyl-2-(4-fluorophenyl)-3-methylcarbamoylbenzofuran-6-yl]methanesulfonylamino}ethyl ester
• CAS NO: 1246280-91-0
• Molecular Weight: 752.671
• Mol File: 1246280-91-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: phosphoric acid ((2R,3S,4R,5R)-5-(3-carbamoyl-[1,2,4]-triazol-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-ylmethyl) ester 2-{[5-cyclopropyl-2-(4-fluorophenyl)-3-methylcarbamoylbenzofuran-6-yl]methanesulfonylamino}ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: phosphoric acid ((2R,3S,4R,5R)-5-(3-carbamoyl-[1,2,4]-triazol-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-ylmethyl) ester 2-{[5-cyclopropyl-2-(4-fluorophenyl)-3-methylcarbamoylbenzofuran-6-yl]methanesulfonylamino}ethyl ester(1246280-91-0)
• EPA Substance Registry System: phosphoric acid ((2R,3S,4R,5R)-5-(3-carbamoyl-[1,2,4]-triazol-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-ylmethyl) ester 2-{[5-cyclopropyl-2-(4-fluorophenyl)-3-methylcarbamoylbenzofuran-6-yl]methanesulfonylamino}ethyl ester(1246280-91-0)

Safety Data

• Hazardous Substances Data: 1246280-91-0(Hazardous Substances Data)

Upstream product

• 1246280-90-9 phosphoric acid ((3aR,4R,6R,6aR)-6-(3-carbamoyl-[1,2,4]-triazol-1-yl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl) ester 2-{[5-cyclopropyl-2-(4-fluorophenyl)-3-methylcarbamoylbenzofuran-6-yl]methanesulfonylamino}ethyl ester 

Downstream Products

• 691852-58-1 nesbuvir 
• 1246280-88-5 2-(N-(5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)benzofuran-6-yl)methylsulfonamido)ethyl dihydrogen phosphate 
• 36791-04-5 ribavirin 

Relevant articles and documents

Design and synthesis of HCV agents with sequential triple inhibitory potentials

The union of HCV-796, a potent selective HCV NS5B polymerase inhibitor, and Ribavirin, a molecule with activities against a wide spectrum of viruses, resulted in a class of new anti-HCV agents with a sequential triple inhibitory mechanism.